WITHDRAWN: Prostate cancer in Asia: A collaborative report
Rui Chen(Second Military Medical University), Yinghao Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Haibo Xia(Nanjing Medical University), Tiejun Pan(Chinese People's Liberation Army), Elijah O. Kehinde(Kuwait University), Gongxian Wang, Chuanliang Xu(Second Military Medical University), Liping Xie(First Affiliated Hospital Zhejiang University), Rainy Umbas, Xu Gao, Jianlin Yuan(Xijing Hospital), Dongwen Wang(Shanxi Medical University), Jian Huang(Soochow University), Kexin Xu(Peking University), Yaoliang Deng(Guangxi Medical University), Jason Yichun Chiu, Shancheng Ren(Shanghai Changzheng Hospital), Xiuheng Liu(Wuhan University), Qiang Ding(Nanjing Medical University), Xiaolei Shi(Second Military Medical University), Ng Chi Fai, Ali Rıza Kural, Zhoujun Shen(Xian Center for Disease Control and Prevention), Chunxiao Liu(Northeast Electric Power University), Changjun Yin(Sun Yat-sen University), Qiang Fu, Xīn Gào(Qingdao University), Jianquan Hou(Soochow University), Danfeng Xu(Second Military Medical University), Liqun Zhou(Peking University), Dalin He(Sichuan University), Fengshuo Jin, Lulin Ma(Peking University), Qiang Wei(Chongqing Medical University), Dingwei Ye(Fudan University), Yong Huang(Shenyang Jianzhu University), Benkang Shi(Qilu Hospital of Shandong University), Seiji Naito(National Center for University Entrance Examinations), Ming Kwong Yiu, Lap Hong Ian, Alexa Cohen, Xiangbo Kong(Chinese Academy of Forestry), W. S. Cheng, Wanhai Xu(Harbin Medical University), Zhangqun Ye(Tongji Hospital), Tadashi Matsuda(Suita Municipal Hospital)
Cited by 2
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
|Cell stem cell|2014|703
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694